ETSDNA結合ドメインとの遺伝子融合は,ヒト腫瘍における染色体転位によって引き起こされる
O Delattre1, J Zucman, B Plougastel
1Laboratoires de Génétique des Tumeurs and URA 620 CNRS, Institut Curie, Paris, France.
Nature
|September 10, 1992
まとめ
ユーイング肉腫は,特定の染色体転位,t(11;22) を含む. この遺伝的変化は,DNA結合ドメインをRNA結合ドメインに置き換えることで,染色体22の鍵となる遺伝子を変えて,ハイブリッド遺伝子を生み出します.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- 腫瘍学 腫瘍学
背景:
- ユーイングの肉腫と原始的な神経赤皮性腫瘍は,特定の染色体転位を共有しています.
- 転位ブレイクポイントのクローニングにより,EWSR1とEWSR2のゲノム領域が特定されました.
- 保存された断片は,潜在的なハイブリッドトランスクリプトを示唆した.
研究 の 目的:
- トランスロケーションによって生じる遺伝的変異を調査する.
- 転位によって影響を受ける特定の遺伝子を特定するために.
- 変異遺伝子の機能的影響を特徴づけるために.
主な方法:
- 保存された制限断片を使用して,人間の補完的なDNAライブラリのスクリーニング.
- 遺伝子発現の分析とオープン・リーディング・フレーム.
- 野生型と転位遺伝子配列の比較.
主要な成果:
- t(11;22) 転位は,染色体22の発現遺伝子の開いた読み取り枠を変更する.
- 推定RNA結合ドメインをコードする配列は,DNA結合ドメインを置き換えます.
- これは,ネズミのFli-1のヒト同類であるヒトを対象としています.
結論:
- ユーイング肉腫における特定の染色体の転位は,新しい遺伝子融合につながります.
- この融合により,機能ドメインが変化したタンパク質が生まれ,遺伝子の調節に影響を与える可能性があります.
- この分子メカニズムを理解することは,ユーイングの肉腫研究にとって極めて重要です.
関連する概念動画
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Nucleotide Excision Repair
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


